Skip to content

Clinical study on electroacupuncture treatment of knee osteoarthritis

Clinical study on electroacupuncture treatment of knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097373
Enrollment
Unknown
Registered
2025-02-18
Start date
2023-08-04
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Electroacupuncture group:The treatment group adopted the treatment mode of conventional acupuncture and moxibustion combined with electroacupuncture apparatus, and selected the points and operation me
Liang Qiu, straight stabbing 1.0 inch
Calf nose, oblique puncture 1.0 inch
Inner knee eye, oblique stab 1.0 inch
Thoroughly stabbing 1.2 inches at Zusanli
Yinling Spring Direct Sting 1.0 inch
San Yin Jiao, with a direct puncture of 1.0 inch
Taixi, piercing straight 0.5 inches. After needling, move the needle 3-5 times, use an electroacupuncture device, use a continuous wave for 5 minutes, and then change to a dense wave for 20 minutes. T
control group:The control group was treated with a specially designed round head blunt needle simulation acupuncture combined with an electroacupuncture device. The selected acupoints and operating me
Taixi, piercing straight 0.5 inches. Simulated acupuncture uses a flat headed needle without a tip, and applies a slight force to the pad attached to the acupoint to make the patient feel the needle w

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meets the Western medical diagnostic criteria for knee osteoarthritis; Patients who meet the Kellgren Lawrence grading criteria II-III in imaging; (2) Patients who meet the Lysholm swelling score; (3) Patients with a depth greater than 3mm in the anechoic zone of fluid accumulation detected by knee joint ultrasound examination; (4) Age >= 50 years old and <= 75 years old, regardless of gender; (5) Patients who have not received acupuncture treatment within three months; (6) Meets knee joint pain for at least 6 months, with a visual analogue score of knee joint pain greater than 4 points but less than or equal to 7 points within the 7 days prior to the screening period; (7) Understand and agree to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe heart, brain, liver, kidney, and lung dysfunction; (2) Patients with indications for knee joint surgery or those who have undergone joint surgery treatment; (3) Has received treatment related to knee osteoarthritis (oral analgesics, intramuscular injection, joint injection, or soft tissue injection of glucocorticoids, etc.), which may affect the efficacy indicators observed in this study; (4) Mental illness patients; (5) Patients with coagulation disorders, lower limb infections, lower limb vascular malformations, and lower limb vascular dysfunction; (6) Individuals with a history of opioid analgesics, sedatives and hypnotics, and alcohol abuse; (7) Patients with indications for pelvic surgery and those who have undergone pelvic surgery treatment; (8) Pregnant and lactating women; (9) Individuals who have participated or are currently participating in other clinical trials within the first month prior to enrollment.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster university of orthopedic index;

Secondary

MeasureTime frame
Lysholm Knee Scoring Scale;Visual Analogue Scale;Lymph node ultrasound examination;Knee joint MRI;

Countries

China

Contacts

Public ContactXiaoyun Wang

Shanghai Research Institute of Acupuncture and Meridian; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

xywang0929@163.com+86 159 2196 7818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026